logo
ResearchBunny Logo
Recent advances in immunotherapy and molecular targeted therapy for gastric cancer

Medicine and Health

Recent advances in immunotherapy and molecular targeted therapy for gastric cancer

Y. Yoshinami and H. Shoji

Gastric cancer remains a major global health challenge, with limited survival rates despite advances in therapy. This exciting review by Yuri Yoshinami and Hirokazu Shoji investigates the latest breakthroughs in immunotherapy and molecular targeted therapies, highlighting the promising role of immune checkpoint inhibitors and their combinations with other treatment approaches.

00:00
00:00
Playback language: English
Abstract
Gastric cancer is a significant global health concern, ranking fourth in both incidence and mortality. Despite advancements in chemotherapy, median survival remains limited (12-15 months). This review examines recent progress in immunotherapy and molecular targeted therapies for gastric cancer, focusing on immune checkpoint inhibitors (ICIs) and their combinations with cytotoxic and targeted agents. Clinical trials demonstrate potential benefits, particularly with anti-PD-1/PD-L1 inhibitors, and ongoing research explores combination strategies to improve outcomes.
Publisher
Future Science OA
Published On
Mar 17, 2023
Authors
Yuri Yoshinami, Hirokazu Shoji
Tags
gastric cancer
immunotherapy
immune checkpoint inhibitors
molecular targeted therapies
clinical trials
PD-1
survival
Listen, Learn & Level Up
Over 10,000 hours of research content in 25+ fields, available in 12+ languages.
No more digging through PDFs, just hit play and absorb the world's latest research in your language, on your time.
listen to research audio papers with researchbunny